Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
Latest news on NOVARTIS AG
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma buys skin cancer drug Odomzo for $175 mn ..
2016 NOVARTIS : Sun Pharma steps up specialty biz, acquires cancer drug in $175 mn de..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma to buy novartis' cancer drug for $175 mil..
2016 NOVARTIS : Alcon`s parent buys Fort Worth startup with treatment for aging eye c..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma gains 1%; to acquire oncology product Odo..
2016 SUN PHARMACEUTICAL INDUSTRIES : Pharma to acquire oncology product Odomzo by Nov..
2016 DECEMBER EDITION EBOOK : In brief
2016 NOVARTIS : Sunovion Licenses Three COPD Therapies from Novartis
2016 NOVARTIS : Patent Issued for Inhibitors for Treating Diseases Characterized by A..
2016 NOVARTIS : Patent Issued for OCT Probe with Pivoting Fiber (USPTO 9517014)
2016 VECTURA : Says Novartis Inks Deal For Three COPD Treatments In The US
2016 E-BOOK EDITION IS ONLINE : In brief
2016 NOVARTIS : buying Fort Worth eye-care startup Encore Vision
2016 NETWORKNEWSBREAKS – CONATUS (N : CNAT) Skyrockets on Exclusive Licensing D..
2016 NOVARTIS : Upsher-smith divests amlactin brand family
2016 NOVARTIS : announces exclusive option, collaboration and license agreement with ..
2016 CONATUS PHARMACEUTICALS : Announces Exclusive Worldwide Option, Collaboration an..
2016 CONATUS PHARMACEUTICALS INC. (NASDAQ : CNAT) Files An 8-K Entry into a Material ..
2016 ACTINIUM PHARMA : ceuticals Appoints Jeannine Larrieux, Ph.D. as Director of Ana..
2016 HERE’S WHAT THE NOVARTIS AG (A : NVS) Deal Means For Conatus Pharmaceutica..
2016 NOVARTIS : bolsters ophthalmology pipeline through acquisition of Encore Vision,..
2016 NOVARTIS : Hogan Lovells Represents Novartis in Purchase of Encore Vision, Inc.
2016 NOVARTIS : announces exclusive option, collaboration and license agreement with ..
2016 WORKERS GIVE A LOTTO PRESENTS AFTER : Euromillions winner delighted with number..
2016 E-BOOK EDITION IS ONLINE : In brief
2016 NOVARTIS : bolsters innovative dermatology portfolio through acquisition of Ziar..
2016 NOVARTIS : receives positive CHMP recommendation for Ilaris to treat rare diseas..
2016 NOVARTIS : receives positive CHMP recommendation for Ilaris® to treat rare disea..
2016 NOVARTIS : drug Votubia® recommended by CHMP for EU approval to treat refractory..
2016 NOVARTIS : bolsters innovative dermatology portfolio through acquisition of Ziar..
2016 NOVARTIS : CAR T cell immunotherapy continues to yield complete responses in leu..
2016 NOVARTIS : LEE011 ribociclib plus letrozole analyses show superior PFS across br..
2016 NOVARTIS : SEG101 crizanlizumab, formerly SelG1 significantly reduces frequency ..
2016 NOVARTIS : How Zika infects the growing brain
2016 NOVARTIS : announces Zykadia® first-line study results showing 16.6 month progre..
2016 NOVARTIS : Fond farewell for Anne as she hands over helm
2016 NOVARTIS` : Innovative Technology-Based Healthcare Program to Increase Availabil..
2016 Global Vaccine Market – Pfizer, CSL Limited, GlaxoSmithKline, Plc, MedI..
2016 Global Depression Drug Market – Forest Laboratories, AstraZeneca, Glaxo..
2016 NOVARTIS : lance un programme pour l’accès aux médicaments au Nigeria
2016 NOVARTIS' : Innovative Technology-Based Healthcare Program to Increase Availabil..
2016 NOVARTIS : launches SMS for Life 2.0 in Nigeria to help improve access to essent..
2016 NOVARTIS : provides update on pegpleranib Phase III clinical trial program in pa..
2016 NOVARTIS : Vodacom Launch ‘SMS for Life 2.0’ in Kaduna
2016 NOVARTIS : Fond farewell for Anne as she hands over helm
2016 NOVARTIS : PAKISTAN’S PHARMA INDUSTRY IS IMMATURE NEED PROMPT REFORM
2016 NOVARTIS : lança SMS for Life 2.0 na Nigéria para ajudar a melhorar o acesso a m..
2016 NOVARTIS : lance SMS for Life 2.0 au Nigeria pour aider à améliorer l’accè..
2016 NOVARTIS : launches SMS for Life 2.0 in Nigeria to help improve Access to Essent..
2016 NOVARTIS : launches SMS for Life 2.0 in Nigeria to help improve access to essent..
2016 NOVARTIS : launches SMS for Life 2.0 in Nigeria to help improve access to essent..
2016 NOVARTIS : provides update on pegpleranib Phase III clinical trial program in pa..
2016 NOVARTIS : Former Horsham Novartis site sold for 16m
2016 NOVARTIS' : Ultibro Breezhaler improved lung function and COPD symptoms after di..
2016 NOVARTIS : LEE011 (ribociclib) plus letrozole analyses show superior PFS across ..
2016 NOVARTIS : Bitter Taster Gene
2016 NOVARTIS : WLF Asks Court to Reject New Liability Theory that Would Drive Prescr..
2016 NOVARTIS : Patent Issued for Silicone Hydrogel Lens with a Crosslinked Hydrophil..
2016 NOVARTIS : Patent Issued for Wash Solution and Method for Affinity Chromatograph..
2016 NOVARTIS : Patent Issued for Systems and Methods for an Electrocapillary Positiv..
2016 NOVARTIS : David Epstein Joins as Special Advisor to Remedy Pharmaceuticals
2016 NOVARTIS : Patent Issued for Systems and Processes for Inserting an Intraocular ..
2016 NOVARTIS : Argentum and Alcon Settle Patent Dispute Over PAZEO®
2016 NOVARTIS : ' Ultibro® Breezhaler® improved lung function and COPD symptoms after..
2016 NOVARTIS : Ultibro Breezhaler Improved COPD Lung Function, Symptoms after Therap..
2016 NOVARTIS : announces Zykadia first-line study results showing 16.6 month progres..
2016 NOVARTIS : ' Lucentis® received EU approval in new indication - Lucentis the onl..
2016 NOVARTIS : GEMS school creates ‘World’s Largest Human Image of an Or..
2016 NOVARTIS : announces Zykadia® first-line study results showing 16.6 month progre..
2016 Une offre de Novartis sur Actelion jugée peu probable
2016 NOVARTIS : data shows Treatment-free Remission rates are consistently above 50% ..
2016 NOVARTIS : survey uncovers real-world burden of myeloproliferative neoplasms (ra..
2016 NOVARTIS : Selexys exit validates Oklahoma as place to start biotech firms
2016 NOVARTIS : SEG101 (crizanlizumab, formerly SelG1) significantly reduces frequenc..
2016 OXFORD BIOMEDICA : Notes Positive Novartis CTL019 Findings
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2017 48 441 M
EBIT 2017 11 334 M
Net income 2017 7 521 M
Debt 2017 16 963 M
Yield 2017 3,71%
P/E ratio 2017 23,17
P/E ratio 2018 20,34
EV / Sales 2017 4,50x
EV / Sales 2018 4,26x
Capitalization 200 997 M
More Financials
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 30
Average target price 80,4 $
Spread / Average Target 5,1%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG3.91%200 997
JOHNSON & JOHNSON3.17%323 362
ROCHE HOLDING LTD.4.69%209 882
PFIZER INC.3.51%204 018
MERCK & CO., INC.11.08%180 289
SANOFI4.75%110 189
More Results